Georgetown University Neurology Clinical Research (GUNCR)

Actively Enrolling Trials

(Current as of August 2023)

Click on the diagnoses below to see our actively enrolling trials

Click on the name of a trial to view the trial’s page on clinicaltrials.gov

ALS, Myasthenia Gravis (MG), & Spinal Muscular Atrophy (SMA)

HEALEY ALS Platform Trial
- Study Coordinator: Gabby Law (gfl11@georgetown.edu)

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures (TALSLB)
- Study Coordinator: Cassie Holmes (cassie.holmes@georgetown.edu)

(MOVR) neuroMuscular ObserVational Research data hub
- Study Coordinator: Gabby Law (gfl11@georgetown.edu)

Epilepsy

Human Epilepsy Project 3 (HEP3)
- Study Coordinator: Michelle Umali (mfu8@georgetown.edu)

Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System. (CORE-VNS)
- Study Coordinator: Michelle Umali (mfu8@georgetown.edu)

Migraine and Headache Disorders

A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine (ASCEND)
- Study Coordinator: David Pisfil (ddp39@georgetown.edu)

An Open-Label, Multiple-Dose Evaluation of the Efficacy and Safety of AXS-07 (meloxicam and rizatriptan) for the Acute Treatment of Migraine in Adults with a Prior Inadequate Response to an Oral CGRP Inhibitor (Axsome AXS-07-304)
- Study Coordinator: Charlie Carpenter (cjc357@georgetown.edu)

Preventive Treatment of migraine: Outcomes for Patients in real-world Healthcare systems (TRIUMPH)
- Study Coordinator: Charlie Carpenter (cjc357@georgetown.edu)

Multiple Sclerosis (MS)

A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (O’HAND)
- Study Coordinator: Daniel Bustamante (db1621@georgetown.edu)

Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Teriflunomide In Relapsing Multiple Sclerosis (RMS) (FENhance) (GN42272)
- Study Coordinator: Nikta Najib (nn358@georgetown.edu)

Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial (TREAT-MS)
- Study Coordinator: David Pisfil (ddp39@georgetown.edu)
The MS-LINK™ Outcomes Study
- Study Coordinator: Aastha Bhatnagar (ab4004@georgetown.edu)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD)

A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Satralizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (Meteoroid)
- Study Coordinator: David Pisfil (ddp39@georgetown.edu)

Neuromyelitis Optica (NMO)

CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)
- Study Coordinator: Daniel Bustamante (db1621@georgetown.edu )

Parkinson’s Disease (PD)

A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the Arm
- Study Coordinator: Luke Lovelace (ll928@georgetown.edu )

Product Surveillance Registry (PSR)
- Study Coordinator: David Pisfil (ddp39@georgetown.edu )

PROSEEK: A Phase 2 Study In Early Parkinson’s Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706 (CLR_18_06 / PROSEEK)
- Study Coordinator: Luke Lovelace (ll928@georgetown.edu )

Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson’s Disease
- Study Coordinator: Luke Lovelace (ll928@georgetown.edu )

Stroke

Anticoagulation in ICH Survivors for Stroke Prevention and Recovery (ASPIRE)
- Study Coordinator: Michelle Umali (mfu8@georgetown.edu)

A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE (LIBREXIA-STROK)
- Study Coordinator: Micah Hamilton (mgh62@georgetown.edu)

Neurology Clinical Research Staff